Muscle MRI reveals distinct abnormalities in genetically proven non-dystrophic myotonias

Neuromuscular Disorders

Volumn 23, Issue 8, 2013, Pages 637-646

  Morrow, Jasper M ^a   Matthews, Emma ^a   Raja Rayan, Dipa L ^a   Fischmann, Arne ^a,b   Sinclair, Christopher D J ^a   Reilly, Mary M ^a   Thornton, John S ^a   Hanna, Michael G ^a   Yousry, Tarek A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

MRI; Myotonia congenita; Non dystrophic myotonia; Paramyotonia congenita

Indexed keywords

BIOLOGICAL MARKER; SODIUM CHANNEL NAV1.4;

ADULT; AGED; ANATOMICAL VARIATION; ARTICLE; BIOACCUMULATION; CLCN1 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE QUALITY; MALE; MUTATOR GENE; MYOGRAPHY; MYOSITIS; MYOTONIA; NON DYSTROPHIC MYOTONIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; SCN4A GENE; SHORT TAU INVERSION RECOVERY;

MRI; MYOTONIA CONGENITA; NON-DYSTROPHIC MYOTONIA; PARAMYOTONIA CONGENITA;

ADULT; AGED; CHLORIDE CHANNELS; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUTATION; MYOTONIC DISORDERS; NAV1.4 VOLTAGE-GATED SODIUM CHANNEL; YOUNG ADULT;

EID: 84880931909     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2013.05.001     Document Type: Article

References (23)

1. Mercuri E., Pichiecchio A., Allsop J., Messina S., Pane M., Muntoni F. Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson Imaging 2007, 25:433-440.
2. Koltzenburg M., Yousry T. Magnetic resonance imaging of skeletal muscle. Curr Opin Neurol 2007, 20:595-599.
3. Matthews E., Fialho D., Tan S.V., et al. The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment. Brain 2010, 133:9-22.
4. Koch M.C., Steinmeyer K., Lorenz C., et al. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 1992, 257:797-800.
5. Raja Rayan D.L., Hanna M.G. Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis. Curr Opin Neurol 2010, 23:466-476.
6. Tan S.V., Matthews E., Barber M., et al. Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies. Ann Neurol 2011, 69:328-340.
7. Kinali M., Arechavala-Gomeza V., Cirak S., et al. Muscle histology vs MRI in Duchenne muscular dystrophy. Neurology 2011, 76:346-353.
8. Fischer D., Kley R.A., Strach K., et al. Distinct muscle imaging patterns in myofibrillar myopathies. Neurology 2008, 71:758-765.
9. Wattjes M.P., Kley R.A., Fischer D. Neuromuscular imaging in inherited muscle diseases. Eur Radiol 2010, 20:2447-2460.
10. + overload, major and reversible contributors to weakness by ion channel leaks. Proc Natl Acad Sci USA 2009, 106:4036-4041.
11. + channelopathies: MRI detects intracellular 23Na accumulation during episodic weakness. Neurology 2006, 67:1151-1158.
12. Kornblum C., Lutterbey G.G., Czermin B., et al. Whole-body high-field MRI shows no skeletal muscle degeneration in young patients with recessive myotonia congenita. Acta Neurol Scand 2010, 121:131-135.
13. Trip J., Pillen S., Faber C.G., Van Engelen B.G.M., Zwarts M.J., Drost G. Muscle ultrasound measurements and functional muscle parameters in non-dystrophic myotonias suggest structural muscle changes. Neuromuscul Disord 2009, 19:462-467.
14. Kornblum C., Lutterbey G., Bogdanow M., et al. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2: a whole body highfield MRI study. J Neurol 2006, 253:753-761.
15. Torriani M., Townsend E., Thomas B.J., Bredella M.A., Ghomi R.H., Tseng B.S. Lower leg muscle involvement in Duchenne muscular dystrophy: an MR imaging and spectroscopy study. Skeletal Radiol 2012, 41:437-445.
16. Narici M.V., Binzoni T., Hiltbrand E., Fasel J., Terrier F., Cerretelli P. In vivo human gastrocnemius architecture with changing joint angle at rest and during graded isometric contraction. J Physiol (Lond) 1996, 496:287-297.
17. Papponen H., Kaisto T., Myllylä V.V., Myllylä R., Metsikkö K. Regulated sarcolemmal localization of the muscle-specific ClC-1 chloride channel. Exp Neurol 2005, 191:163-173.
18. Ababneh Z.Q., Ababneh R., Maier S.E., et al. On the correlation between T[2] and tissue diffusion coefficients in exercised muscle: quantitative measurements at 3T within the tibialis anterior. MAGMA 2008, 21:273-278.
19. Psatha M., Wu Z., Gammie F.M., et al. A longitudinal MRI study of muscle atrophy during lower leg immobilization following ankle fracture. J Magn Reson Imaging 2012, 35:686-695.
20. Gloor M., Fasler S., Fischmann A., et al. Quantification of fat infiltration in oculopharyngeal muscular dystrophy: comparison of three MR imaging methods. J Magn Reson Imaging 2011, 33:203-210.
21. Ploutz-Snyder L.L., Nyren S., Cooper T.G., Potchen E.J., Meyer R.A. Different effects of exercise and edema on T2 relaxation in skeletal muscle. Magn Reson Med 1997, 37:676-682.
22. Poliachik S.L., Friedman S.D., Carter G.T., Parnell S.E., Shaw D.W. Skeletal muscle edema in muscular dystrophy: clinical and diagnostic implications. Phys Med Rehabil Clin N Am 2012, 23:107-122. xi.
23. Wren T.A.L., Bluml S., Tseng-Ong L., Gilsanz V. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. AJR Am J Roentgenol 2008, 190:W8-W12.